Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that […]
The day after Geron news: a realistic outlook for the stem cell field Read More »
Many of you may have heard that there is a Vatican stem cell meeting . Today the Vatican held the first day of its adult stem cell conference. Embryonic stem cells remained not surprisingly uninvited. This conference is an unprecedented event in the thousands of years of history of The Church so not surprisingly many
What are the goals of the Vatican stem cell meeting and why no press releases so far? Read More »
What is Myc? Often when we dig a little into the science of stem cells, people get turned off by all the strange names of molecules and jargon. However, whether you are a scientist, patient, investor, reporter, etc. there are some aspects of stem cell science that are ‘musts’ to know about. For example, you
Want to understand stem cells? Then you have to know Myc Read More »
In mid-November the Catholic Church, in fact the Vatican itself, will do something it has never done before in its very long existence. It will hold a conference on stem cells. Perhaps equally unusual and of interest is the fact that the basis for this conference is a $1 million (USD) gamble by the Vatican
More on the Vatican $1 million gamble on NeoStem and their upcoming conference in Rome Read More »
What the heck happened to The New Scientist? An anti-embryonic stem cell piece they just recently published was an exercise in weird, moral obfuscation. Quite a few scientists and policy makers are fairly regular readers of The New Scientist. They might start reconsidering how they want to spend that $99/year. Why not use it to
The New Scientist goes after ES cells with strange opinion piece Read More »
There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court
Anti-cure impact of Errant EU stem cell patent decision Read More »
There are many stories in the news about stem cells right now. Some of the stories are positive and some are negative in terms of the actual news. A separate issue is that some of the stories do a good job, while others are very inaccurate or use the news to confuse and push their
Stem cells in the media today: the good and the ugly Read More »
I’ve posted before about the propaganda machine that is actively promoting an anti-embryonic stem cell agenda. This machine is still out there and as many of us discussed at the recent World Stem Cell Summit, it seems to be working far better than our efforts to promote our cause. What do the folks on the
Strategies of Anti-Stem Cell Propaganda War Machine Read More »
This past week a paper came out in Nature that reported the successful production of human ES cells using somatic cell nuclear transfer (SCNT) technology. It is no exaggeration to say that this paper generated massive international media coverage, in part because of the links between this technology and the potential for human cloning, both
Why all the fuss about SCNT-derived ES cell paper? Read More »
Drs. James Sherley and Theresa Deisher are the two adult stem cell researchers who sued the federal government over federal funding of ESC research. They claimed that NIH funding of ESC research violated the law and also was unfair to them. This case has been bouncing around in various courts over the last couple years
Stem cell opponents appeal federal ruling: what does this mean? Read More »